Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP447761.RAh1BHtNurF5gPBZ39dSf1X0R5ufkHckKooW5riNZUjN8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP447761.RAh1BHtNurF5gPBZ39dSf1X0R5ufkHckKooW5riNZUjN8130_assertion type Assertion NP447761.RAh1BHtNurF5gPBZ39dSf1X0R5ufkHckKooW5riNZUjN8130_head.
- NP447761.RAh1BHtNurF5gPBZ39dSf1X0R5ufkHckKooW5riNZUjN8130_assertion description "[Recent experiments have demonstrated that the Polycomb group (PcG) gene EZH2 is highly expressed in metastatic prostate cancer and in lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP447761.RAh1BHtNurF5gPBZ39dSf1X0R5ufkHckKooW5riNZUjN8130_provenance.
- NP447761.RAh1BHtNurF5gPBZ39dSf1X0R5ufkHckKooW5riNZUjN8130_assertion evidence source_evidence_literature NP447761.RAh1BHtNurF5gPBZ39dSf1X0R5ufkHckKooW5riNZUjN8130_provenance.
- NP447761.RAh1BHtNurF5gPBZ39dSf1X0R5ufkHckKooW5riNZUjN8130_assertion SIO_000772 14532106 NP447761.RAh1BHtNurF5gPBZ39dSf1X0R5ufkHckKooW5riNZUjN8130_provenance.
- NP447761.RAh1BHtNurF5gPBZ39dSf1X0R5ufkHckKooW5riNZUjN8130_assertion wasDerivedFrom befree-20140225 NP447761.RAh1BHtNurF5gPBZ39dSf1X0R5ufkHckKooW5riNZUjN8130_provenance.
- NP447761.RAh1BHtNurF5gPBZ39dSf1X0R5ufkHckKooW5riNZUjN8130_assertion wasGeneratedBy ECO_0000203 NP447761.RAh1BHtNurF5gPBZ39dSf1X0R5ufkHckKooW5riNZUjN8130_provenance.